International Clinical Trial: Strengthen the long-term management of hyperkalemia in hemodialysis patients based on the pattern of blood potassium changes

Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119050) titled 'Strengthen the long-term management of hyperkalemia in hemodialysis patients based on the pattern of blood potassium changes' on Feb. 14.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Lin'an District First People's Hospital of Hangzhou (Affiliated Lin'an People's Hospital of Hangzhou Medical College)

Condition: Hyperkalemia

Intervention: Experimental Group:Blood potassium (5.0-6.0mmol/L), 5g of sodium zirconium cyclosilicate orally administered daily on non-dialysis days Blood potassium (>6.0mmol/L), 10g of sodium zirconium cyclosilicate orally per day on non-dialysis days After ...